Skip to main content

Univ. of Manchester Buys Cell Biosciences System

NEW YORK (GenomeWeb News) – Cell Biosciences has sold one of its protein analysis systems to The University of Manchester, the company said today.

The university will use the system in its Stem Cell and Leukemia Proteomics Laboratory to study how phosphoprotein signaling processes in hematopoietic stem calls are different during leukemia.

The platform is a nanofluidic immunoassay system designed to analyze extremely small biological samples, and it can measure cell signaling proteins reproducibly in numbers as small as 25 cells.

Financial terms of the agreement were not released.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.